<DOC>
	<DOCNO>NCT00487422</DOCNO>
	<brief_summary>The purpose study determine whether prucalopride safe effective treatment chronic constipation elderly patient . Hypothesis : Prucalopride 2 mg 4 mg give daily 12 week superior placebo treatment patient chronic constipation well tolerate patient</brief_summary>
	<brief_title>Efficacy Safety Study Prucalopride Treatment Elderly Patients With Chronic Constipation</brief_title>
	<detailed_description>This multicentre , randomise , Phase III trial parallel-group design , consist 2 week drug-free run-in period , follow 4-week , double-blind , placebo-controlled treatment period . During run-in period , subject 's bowel habit document existence constipation confirm . At start period , exist laxative medication withdrawn subject instruct change diet lifestyle trial . Subjects allowed take laxative ( DulcolaxÂ® ) rescue medication throughout trial , bowel movement three consecutive day . Subjects enter double-blind period constipation show present run-in period . Patients randomly allocate one 4 treatment arm : 1 mg , 2 mg , 4 mg R108512 placebo , 25 % chance treatment group . During double-blind period , subject treat 4 week either 1 mg , 2 mg 4 mg R108512 placebo , give daily breakfast .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<criteria>1 . Male female subject 65 65 year age . 2 . History constipation ; subject report , average , two few spontaneous bowel movement per week result feel complete evacuation one follow least 6 month selection visit : 1. hard ( little ball ) and/or hard stool least quarter stool 2. sensation incomplete evacuation follow least quarter stool 3. strain defecation least quarter stool . The criterion applicable spontaneous bowel movement , i.e. , precede within period 24 hour intake laxative agent use enema . Subjects never spontaneous bowel movement consider constipate eligible trial . 1 . Subjects constipation think druginduced , subject use disallowed medication . 2 . Subjects suffer endocrine disorder , metabolic disorder neurologic disorder . 3 . Subjects main complaint abdominal pain . 4 . Subjects know megacolon/megarectum diagnosis pseudoobstruction . 5 . Constipation result surgery . 6 . Known suspected organic disorder large bowel , i.e . obstruction , carcinoma , inflammatory bowel disease . 7 . Malignancies AIDS . 8 . Known serious illness : clinically significant cardiac , vascular , pulmonary , gastrointestinal , endocrine , neurological , psychiatric metabolic disturbance . Patients know diverticulosis may include . 9 . Subjects serum creatinine concentration &gt; 2 mg/dL ( &gt; 180 micromol/L ) . 10 . Subjects clinically significant abnormality haematology , urinalysis , blood chemistry .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>constipation</keyword>
	<keyword>prucalopride</keyword>
	<keyword>QOL</keyword>
	<keyword>SCBM</keyword>
	<keyword>PAC-SYM</keyword>
</DOC>